01:17 AM EDT, 08/06/2026 (MT Newswires) -- Galenica (GALE.SW) said Thursday its attributable profit for the first half declined while net sales grew year over year. Net profit attributable to shareholders for the six months ended June 30 was 66.4 million francs, compared with 88.3 million francs earlier. EPS moved to 1.33 francs from 1.77 francs. The Swiss pharmaceutical and logistics company's net sales were 2.14 billion francs, compared with 2 billion francs a year ago. For the full-year 2026, Galenica reiterated its sales growth guidance of between 5% and 7%. The company also plans to pay a dividend at least at the 2025 level.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.